Technology · September 2026
What these devices measure is genuinely useful. What they treat is far more limited than the advertising suggests. And a quiet insurance change in 2026 may matter more than the hardware.
Patients ask us about this more often than any other technology question: can a watch, a band, or an app actually help with chronic pain? The honest answer has two halves — what these devices can measure is genuinely useful, and what they can treat is far more limited than the advertising suggests.
Most consumer wearables are activity and sleep trackers. They are not pain treatments, and nothing you buy online will make a facet joint or an irritated nerve stop hurting.
What they can do is show patterns that are genuinely hard to recall in a fifteen-minute appointment. How much are you actually walking in a week? Did your activity increase after an injection, or did you rest through the window of relief? Are the bad days following poor sleep?
Those questions matter clinically. Pain diaries have always been useful; the difference is that a device records the data without requiring you to remember.
There are FDA-cleared devices intended to treat pain, and there are consumer wellness gadgets. They are not the same category, and the marketing rarely makes the distinction obvious.
Before buying anything that promises pain relief, it is fair to ask what evidence supports it, whether it has been cleared for the condition you actually have, and what the return policy is.
The larger shift is happening on the insurance side. Medicare has covered a category called Remote Therapeutic Monitoring since 2022 — a way for clinicians to be paid for reviewing data patients generate between visits, such as pain scores, exercise adherence, and functional progress.
Until recently the rules made it impractical for many musculoskeletal patients. Practices had to collect at least 16 days of data in a 30-day period and spend at least 20 minutes of management time before anything was billable, which excluded people who only needed a short stretch of monitoring — for example, the few weeks after a procedure.
Effective January 2026, Medicare added codes that recognize shorter monitoring periods and briefer check-ins. That is a technical change, but its practical effect is real: it makes it viable for a clinic to stay in contact with patients between visits rather than waiting for the next appointment.
The useful version is not a gadget. It is a feedback loop:
For a treatment like radiofrequency ablation or an epidural injection, where the question is always "did this help, how much, and for how long," that record is clinically valuable rather than merely interesting.
We do not currently offer a remote monitoring program, and we are not going to announce one before it exists. It is something we are evaluating, and if we do build it, it will be because it improves care between visits — not because a billing code became available.
In the meantime, there is a low-technology version that works: after a procedure, keep a simple note of how your pain changes over the following weeks. Bring it to your follow-up. It genuinely helps us plan what comes next.
Health data from consumer devices is not always protected the way medical records are. HIPAA covers your clinic and your health plan; it does not automatically cover an app you downloaded. Before connecting an app to anything, it is worth reading what it does with your data.
This article is general information about developments in pain medicine. It is not medical advice, not a recommendation for or against any product or treatment, and it does not describe services offered at CPMC unless stated. Whether any of this applies to you depends on your diagnosis and history — that is a conversation for your appointment.